China: Strict action to be taken against manufacturers of cosmetics found containing Betamethasone dipropionate

On October 18, 2022, China's National Medical Products administration notified that certain cosmetics samples inspected under the Yunnan Institute of Food and Drug Supervision and Inspection contained Betamethasone dipropionate (a glucocorticoid steroid with anti-inflammatory and immunosuppressive abilities) which are prohibited for use in cosmetics in China. The authorities are expected to file a lawsuit against manufacturers involved and strict legal action will be taken on all stakeholders if found guilty.